Quick Takeaways Why It Matters? This Petco rollout gives Fera Pets a much bigger retail stage and moves its vet-founded, “clean-label” supplements from niche online channels into mainstream, in‑store traffic. This move will raise competitive pressure on legacy suppl...
Quick Takeaways Why It Matters? This GRAS clearance gives Hill’s and Bond a first‑mover, “next‑gen” animal protein that can start showing up in premium dog foods as a sustainable, precision‑fermented alternative to conventional lamb. From a market an...
Quick Takeaways Why It Matters? A new proprietary CNS asset from Orion, exclusively commercialized by Zoetis in the US, that taps into fast‑growing demand for medical management of canine anxiety and should expand the addressable market beyond situational noise phobia toward mo...
Quick Takeaways Why It Matters? Ceva is using this JV to turn Japan from a peripheral presence into a true platform market, bolting its global livestock and pet portfolio onto Bussan Animal Health’s 75‑year brand, field force, and ~€40M business to create a full‑line ...
Quick Takeaways: Why It Matters? Volition is positioning Nu.Q Vet Feline as a potential first scalable, affordable blood test for feline lymphoma, with performance (86% sensitivity at 97% specificity) strong enough to support real-world screening, not just “rule...
Quick Takeaways Why It Matters? Gallant is on track to create one of the first mass‑market, disease‑modifying OA biologics in companion animals, shifting regenerative medicine from niche referral centers into everyday general practice via a simple, ready‑to‑use IV product. ...
Quick Takeaways: Why It Matters? A first commercial push to sell “verified sustainability” alongside animal health, using VAXA‑powered, low‑carbon spirulina and omega oil to let early‑adopter protein, dairy, aquaculture, and petfood producers meaningfully lower feed‑related emission...
Quick Takeaways: Why It Matters? Pet Honesty is doubling down on a science-first positioning in the pet supplement aisle by formalizing “The Honest Difference” around clean, filler‑free formulations, clinically studied ingredients, third‑party testing, and vet‑backed ...
Quick Takeaways: Why It Matters? Genflow’s early canine SIRT6 data are strong enough that big animal‑health players now want a closer look, but not yet strong enough for anyone to sign a deal. The expanded web of NDAs suggests real strategic interest ...
Quick Takeaways Why It Matters? Jaguar is extending its rainforest‑derived GI platform from niche equine/calf use into the much larger companion‑dog market with Neonorm Dog, giving it an OTC, plant‑based gut‑health brand that can sit alongside its prescription Canalevi...
